HCA Healthcare agrees in principle to settle: RBC raises target for HCA Healthcare stock
Published on 10/09/2026 at 15:07 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSKey points in brief
- HCA Healthcare and Mission Hospital reached an agreement in principle on September 30, 2026, in an antitrust case.
- RBC Capital raised its HCA target from USD 435.00 to USD 496.00 on October 7, 2026.
- Second-quarter 2026 revenue increased 8.70 percent to USD 20.23 billion.
- HCA Healthcare stock was EUR 397.85 at Lang & Schwarz on October 9, 2026, up 0.24 percent versus the prior close.
HCA Healthcare and Mission Hospital had reached an agreement in principle on September 30, 2026, to resolve claims in an antitrust lawsuit, Asheville.com reported on October 9, 2026. The development adds a legal overhang to HCA Healthcare stock while RBC Capital raised its price target from USD 435.00 to USD 496.00 on October 7, 2026, according to Markets Insider.
Three dated signals for HCA
On July 14, 2026, HCA revised its full-year revenue guidance to USD 77.0 billion to USD 79.5 billion, while its earnings outlook was cut to USD 28.70 to USD 30.50 per share, as summarized by Yahoo Finance. On July 24, 2026, the company reported second-quarter revenue of USD 20.23 billion and earnings per share of USD 7.59, up 8.70 percent year over year, according to MarketBeat. On October 7, 2026, RBC raised its target by USD 61.00, a 14.02 percent increase from USD 435.00.
What does the target raise signal?
RBC's new USD 496.00 target is 14.02 percent above its former USD 435.00 target, but the note also says second-half cadence expectations had been reset. That combination matters because the second-quarter revenue increase came alongside a more cautious full-year earnings outlook.
The legal development adds a separate variable. The September 30 agreement in principle concerns claims related to HCA's Mission Hospital operations in western North Carolina, while Asheville.com reported that other proceedings involving Mission and HCA continue. The company has said it complied with state and federal antitrust laws, according to the report.
Next date is October 27
HCA Healthcare is scheduled to hold its third-quarter 2026 earnings call on October 27, 2026, at 10:00 a.m. Eastern Time, according to StockTitan. Yahoo Finance says analysts expect diluted earnings per share of USD 6.73 for the third quarter, compared with USD 6.96 in the year-ago quarter.
HCA stock holds near EUR 398
HCA Healthcare was trading at EUR 397.85 at Lang & Schwarz on October 9, 2026 at 3:02 p.m. CEST, up 0.24 percent versus the prior close of EUR 396.90 on October 8, 2026. The finance quote for the NYSE listing showed USD 445.01 at 1:06 p.m. CEST on October 9, 2026, while its 52-week range was USD 353.99 to USD 556.52.
The further course of trading is shown by the continuously updated real-time quote of HCA Healthcare stock.
HCA Healthcare stock facts
- Company: HCA Healthcare, Inc.
- ISIN: US40412C1018
- Ticker: HCA
- Primary exchange: NYSE
- Price Lang & Schwarz (as of October 9, 2026, 3:02 p.m. CEST): EUR 397.85
- Change versus prior close: plus 0.24 percent
- Prior close Lang & Schwarz (October 8, 2026): EUR 396.90
- Market capitalization: USD 96.3 billion (as of October 9, 2026)
- 52-week range: USD 353.99-556.52 (as of October 8, 2026)
- Sector / Industry: Healthcare / Medical Care Facilities
- Next earnings date: October 27, 2026
Market context: Market report S&P 500.
